TipRanks
Go Ultimate55% OFF

Susan Ringdal Insider Profile

4 Followers

Susan Ringdal, Vice-President at Hikma Pharmaceuticals, holds 121.50K shares in Hikma Pharmaceuticals (Ticker: GB:HIK).

Susan Ringdal's Trading History

HIK
Hikma Pharmaceuticals
Sep 22, 2026Vice-PresidentUninformative Buy26.89K£2.10M
GB:HIK
Insider Shares: 121.50K (5.82%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Sep 22, 2026Uninformative Buy£26.89K1,684£1.60K――
Jun 02, 2026Informative Sell£553.84K38,222£1.45K-23.90%―
May 06, 2026Uninformative Buy£32.95K2,337£1.41K――
Sep 23, 2025Uninformative Buy£24.43K1,499£1.63K――
Aug 13, 2025Informative Sell£504.26K28,393£1.78K+3.60%―

You May Also Like

Susan Ringdal insider profile FAQ

What is the percentage of profitable transactions made by Susan Ringdal?
The percentage of profitable transactions made by Susan Ringdal is 67%.
What is the average return per transaction made by Susan Ringdal?
The average return per transaction made by Susan Ringdal is 8.90%.
What stocks does Susan Ringdal hold?
Susan Ringdal holds: GB:HIK stocks.
What was Susan Ringdal’s latest transaction?
Susan Ringdal’s latest transaction was an Uninformative Buy of 26.89K .
What was Susan Ringdal's most profitable transaction?
Susan Ringdal’s most profitable transaction was an Informative Sell of GB:HIK stock on March 4, 2025. The return on the trade was 40.10%.
What is Susan Ringdal's role in Hikma Pharmaceuticals?
Susan Ringdal's role in Hikma Pharmaceuticals is Vice-President.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.